Alyeska Investment Group
NAUT icon

Alyeska Investment Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Alyeska Investment Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-253,468
Closed -$494K – 706
2025
Q4 		$494K Hold
253,468
– – ﹤0.01% 558
2025
Q3 		$214K Hold
253,468
– – ﹤0.01% 575
2025
Q2 		$184K Hold
253,468
– – ﹤0.01% 538
2025
Q1 		$218K Hold
253,468
– – ﹤0.01% 486
2024
Q4 		$426K Sell
253,468
-187,550
-43% -$449K ﹤0.01% 521
2024
Q3 		$1.26M Hold
441,018
– – 0.01% 448
2024
Q2 		$1.03M Hold
441,018
– – 0.01% 462
2024
Q1 		$1.3M Hold
441,018
– – 0.01% 402
2023
Q4 		$1.32M Sell
441,018
-4,968
-1% -$14.2K 0.01% 395
2023
Q3 		$1.41M Hold
445,986
– – 0.01% 405
2023
Q2 		$1.73M Sell
445,986
-30,443
-6% -$87.7K 0.01% 418
2023
Q1 		$1.32M Hold
476,429
– – 0.01% 379
2022
Q4 		$858K Hold
476,429
– – 0.01% 356
2022
Q3 		$1.01M Sell
476,429
-19,557
-4% -$49.2K 0.01% 342
2022
Q2 		$1.33M Hold
495,986
– – 0.02% 445
2022
Q1 		$2.15M Hold
495,986
– – 0.02% 409
2021
Q4 		$2.57M Hold
495,986
– – 0.03% 399
2021
Q3 		$3.04M Sell
495,986
-919,653
-65% -$7.33M 0.04% 417
2021
Q2 		$13.5M Buy
1,415,639
+668,648
+90% +$7.24M 0.16% 177
2021
Q1 		$10.3M Sell
746,991
-53,009
-7% -$734K 0.13% 196
2020
Q4 		$8.68M Sell
800,000
-6,400
-0.8% -$67.4K 0.12% 212
2020
Q3 		$8.72M Buy
+806,400
New +$8.6M 0.13% 194

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Alyeska Investment Group's NAUT Position: Q1 2026 in Review

Alyeska Investment Group sold out of Nautilus Biotechnolgy (NAUT) in Q1 2026, closing a stake of 253,468 shares — an estimated $494K sold.

Alyeska Investment Group first reported a position in NAUT in Q3 2020 and held it in 22 quarters. The position peaked at $13.5M in Q2 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Alyeska Investment Group reported no remaining Nautilus Biotechnolgy position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 253,468 Nautilus Biotechnolgy shares in Q1 2026, an estimated $494K.
  • Alyeska Investment Group first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 22 quarters.
  • Alyeska Investment Group's Nautilus Biotechnolgy position peaked at $13.5M in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.